NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022.


Journal

Journal of the National Comprehensive Cancer Network : JNCCN
ISSN: 1540-1413
Titre abrégé: J Natl Compr Canc Netw
Pays: United States
ID NLM: 101162515

Informations de publication

Date de publication:
03 2022
Historique:
entrez: 11 3 2022
pubmed: 12 3 2022
medline: 22 3 2022
Statut: ppublish

Résumé

The NCCN Guidelines for Head and Neck Cancers address tumors arising in the oral cavity (including mucosal lip), pharynx, larynx, and paranasal sinuses. Occult primary cancer, salivary gland cancer, and mucosal melanoma (MM) are also addressed. The specific site of disease, stage, and pathologic findings guide treatment (eg, the appropriate surgical procedure, radiation targets, dose and fractionation of radiation, indications for systemic therapy). The NCCN Head and Neck Cancers Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize the panel's most recent recommendations regarding management of HPV-positive oropharynx cancer and ongoing research in this area.

Identifiants

pubmed: 35276673
doi: 10.6004/jnccn.2022.0016
pii: jnccn2003glins
doi:
pii:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

224-234

Auteurs

Jimmy J Caudell (JJ)

Moffitt Cancer Center.

Maura L Gillison (ML)

The University of Texas MD Anderson Cancer Center.

Ellie Maghami (E)

City of Hope National Medical Center.

Sharon Spencer (S)

O'Neal Comprehensive Cancer Center at UAB.

David G Pfister (DG)

Memorial Sloan Kettering Cancer Center.

Douglas Adkins (D)

Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.

Andrew C Birkeland (AC)

UC Davis Comprehensive Cancer Center.

David M Brizel (DM)

Duke Cancer Institute.

Paul M Busse (PM)

Massachusetts General Hospital Cancer Center.

Anthony J Cmelak (AJ)

Vanderbilt-Ingram Cancer Center.

A Dimitrios Colevas (AD)

Stanford Cancer Institute.

David W Eisele (DW)

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

Thomas Galloway (T)

Fox Chase Cancer Center.

Jessica L Geiger (JL)

Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.

Robert I Haddad (RI)

Dana-Farber/Brigham and Women's Cancer Center.

Wesley L Hicks (WL)

Roswell Park Comprehensive Cancer Center.

Ying J Hitchcock (YJ)

Huntsman Cancer Institute at the University of Utah.

Antonio Jimeno (A)

University of Colorado Cancer Center.

Debra Leizman (D)

Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.

Loren K Mell (LK)

UC San Diego Moores Cancer Center.

Bharat B Mittal (BB)

Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

Harlan A Pinto (HA)

Stanford Cancer Institute.

James W Rocco (JW)

The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.

Cristina P Rodriguez (CP)

Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance.

Panayiotis S Savvides (PS)

Mayo Clinic Cancer Center.

David Schwartz (D)

St. Jude Children's Research Hospital/The University of Tennessee Health Science Center.

Jatin P Shah (JP)

Memorial Sloan Kettering Cancer Center.

David Sher (D)

UT Southwestern Simmons Comprehensive Cancer Center.

Maie St John (M)

UCLA Jonsson Comprehensive Cancer Center.

Randal S Weber (RS)

The University of Texas MD Anderson Cancer Center.

Gregory Weinstein (G)

Abramson Cancer Center at the University of Pennsylvania.

Frank Worden (F)

University of Michigan Rogel Cancer Center.

Justine Yang Bruce (J)

University of Wisconsin Carbone Cancer Center.

Sue S Yom (SS)

UCSF Helen Diller Family Comprehensive Cancer Center.

Weining Zhen (W)

Fred & Pamela Buffett Cancer Center; and.

Jennifer L Burns (JL)

National Comprehensive Cancer Network.

Susan D Darlow (SD)

National Comprehensive Cancer Network.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH